Stay updated on TRx0237 in Mild Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the TRx0237 in Mild Alzheimer's Disease Clinical Trial page.

Latest updates to the TRx0237 in Mild Alzheimer's Disease Clinical Trial page
- ChecktodayChange DetectedNo significant data changes detected; the modifications appear limited to formatting and minor UI adjustments in the Study Details page, with location lists and core study information unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check22 days agoChange Detected- Added a prominent notice about potential outages due to funding and updated operating status references; updated version to v3.2.0. - Removed v3.1.0 declaration.SummaryDifference3%

- Check30 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, updating the page version identifier.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved explicit mentions of Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, and Substandard Drugs; overall content framing in the safety/quality area appears diminished.SummaryDifference0.3%

- Check44 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, indicating a patch-level release. The 'Back to Top' element was removed, but there are no other substantive changes to core content such as pricing or time-sensitive information.SummaryDifference0.2%

- Check51 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

Stay in the know with updates to TRx0237 in Mild Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRx0237 in Mild Alzheimer's Disease Clinical Trial page.